Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development) - Image 1

£107.98

Humana Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)

Name: Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)
Brand: Humana
Price: 107.98 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 75 days · 75 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 75 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £108 (69 days, 92.0%)

Price range: £107 - £108

Price levels: 2 different prices over 75 days

Description

Antibody-drug conjugates (ADCs) stand at the verge of a transformation. Scores of clinical programs have yielded only a few regulatory approvals, but a wave of technological innovation now empowers us to overcome past technical challenges. This volume focuses on the next generation of ADCs and the innovations that will enable them. The book inspires the future by integrating the field’s history with novel strategies and cutting-edge technologies. While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties. However, the combination of small and large molecules imposes deep complexity to lead optimization, pharmacokinetics, toxicology, analytics and manufacturing. The field has made significant advances in all of these areas by improving target selection, ADC design, manufacturing methods and clinical strategies. These innovations will inspire and educate scientists who are designing next-generation ADCs with the potential to transform the lives of patients.

Product Specifications

Brand: Humana
Format: hardcover
ASIN: 3319781537
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 11 June 2018
Listed Since: 15 February 2018

Barcode

No barcode data available

Humana Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Antibody-Drug Conjugates: 1045 (Methods in Molecular Biology, 1045)

Antibody-Drug Conjugates: Methods and Protocols: 2078 (Methods in Molecular Biology, 2078)

Cytotoxic Payloads for Antibody–Drug Conjugates: Volume 71 (Drug Discovery Series)

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

Immuno-Oncology: Cellular and Translational Approaches (Methods in Pharmacology and Toxicology)

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Springer - Immunotherapy of Cancer: An Innovative Treatment

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Diagnostic and Therapeutic Antibodies: 40 (Methods in Molecular Medicine, 40)

Critical Developments in Cancer Immunotherapy

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Multifunctional Nanocarriers (Micro and Nano Technologies)

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Principles of Cancer Biotherapy

Immunotherapy in Translational Cancer Research (Translational Oncology)

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Recombinant Antibodies for Immunotherapy

Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)

Chemical Linkers in Antibody–Drug Conjugates (ADCs): Volume 81 (Drug Discovery Series)

Nanomedicine in Cancer Immunotherapy (Woodhead Publishing Series in Biomaterials)